Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $72.5000 (-1.69%) ($68.7500 - $73.7500) on Wed. Feb. 13, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 20.3% (three month average) | RSI | 67 | Latest Price | $72.5000(-1.69%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.8% a day on average for past five trading days. | Weekly Trend | CAPR advances 8.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -10.15% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -10.15% (StdDev 20.3%) | Hourly BBV | 0 () | Intraday Trend | -1.7% | | | |
|
5 Day Moving Average | $67.61(7.23%) | 10 Day Moving Average | $63.63(13.94%) | 20 Day Moving Average | $63.86(13.53%) | To recent high | -21.6% | To recent low | 457.7% | Market Cap | $1.428b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |